Agalsidase alfa en es it fr

Agalsidase alfa Brand names, Agalsidase alfa Analogs

Agalsidase alfa Brand Names Mixture

  • No information avaliable

Agalsidase alfa Chemical_Formula

C2029H3080N544O587S27

Agalsidase alfa RX_link

http://www.rxlist.com/cgi/generic3/fabrazyme.htm

Agalsidase alfa fda sheet

Agalsidase alfa msds (material safety sheet)

Agalsidase alfa Synthesis Reference

No information avaliable

Agalsidase alfa Molecular Weight

45351.6

Agalsidase alfa Melting Point

No information avaliable

Agalsidase alfa H2O Solubility

No information avaliable

Agalsidase alfa State

Liquid

Agalsidase alfa LogP

-0.307

Agalsidase alfa Dosage Forms

Powder for solution

Agalsidase alfa Indication

For treatment of Fabry's disease (alpha-galactosidase A deficiency)

Agalsidase alfa Pharmacology

Used in the treatment of Fabry disease, an X-linked genetic disorder of glycosphingolipid metabolism. The disease is characterized by a deficiency of the lysosomal enzyme alpha-galactosidase A, which leads to progressive accumulation of glycosphingolipids, predominantly GL-3, in many body tissues. Clinical manifestations of Fabry disease include renal failure, cardiomyopathy, and cerebrovascular accidents. Fabrazyme is intended to provide an exogenous source of alpha-galactosidase A and to limit the accumulation of these glycolipids in the tissues.

Agalsidase alfa Absorption

No information avaliable

Agalsidase alfa side effects and Toxicity

No information avaliable

Agalsidase alfa Patient Information

BIOD00075.html

Agalsidase alfa Organisms Affected

Humans and other mammals